Global Trial in APG2575 for Patients With CLL/SLL
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
135 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ascentage Investigative Site
Gosford, Australia
Completed - Ascentage Investigative Site
Perth, Australia
Completed - Ascentage Investigative Site
Westmead, Australia
Completed
- Ascentage Investigative Site
Ghent, Belgium
Recruiting - Ascentage Investigative Site
La Louvière, Belgium
Recruiting - Ascentage Investigative Site
Leuven, Belgium
Recruiting - Ascentage Investigative Site
Ottignies, Belgium
Recruiting - Ascentage Investigative Site
Roeselare, Belgium
Recruiting
- Ascentage Investigative Site
Sofia, Bulgaria
Recruiting - Ascentage Investigative Site
Sofia, Bulgaria
Recruiting - Ascentage Investigative Site
Sofia, Bulgaria
Recruiting - Ascentage Investigative Site
Sofia, Bulgaria
Recruiting
- Ascentage Investigative Site
Halifax, Nova Scotia, Canada
Recruiting
- Ascentage Investigative Site
Hefei, Anhui, China
Recruiting - Ascentage Investigative Site
Beijing, Beijing Municipality, China
Recruiting - Ascentage Investigative Site
Fuzhou, Fujian, China
Recruiting - Ascentage Investigative Site
Foshan, Guangdong, China
Recruiting - Ascentage Investigative Site
Guangzhou, Guangdong, China
Recruiting - Ascentage Investigative Site
Nanning, Guangxie, China
Recruiting - Ascentage Investigative Site
Zhengzhou, Henan, China
Recruiting - Ascentage Investigative Site
Wuhan, Hubei, China
Recruiting - Ascentage Investigative Site
Chenzhou, Hunan, China
Recruiting - Ascentage Investigative Site
Nanjing, Jiangsu, China
Recruiting - Ascentage Investigative Site
Suzhou, Jiangsu, China
Recruiting - Ascentage Investigative Site
Wuxi, Jiangsu, China
Recruiting - Ascentage Investigative Site
Nanchang, Jiangxi, China
Recruiting - Ascentage Investigative Site
Xi'an, Shaanxi, China
Recruiting - Ascentage Investigative Site
Binzhou, Shandong, China
Recruiting - Ascentage Investigative Site
Taiyuan, Shanxi, China
Recruiting - Ascentage Investigative Site
Luzhou, Sichuan, China
Recruiting - Ascentage Investigative Site
Yibin, Sichuan, China
Recruiting - Ascentage Investigative Site
Guangzhou, China
Recruiting
- Ascentage Investigative Site
Hradec Králové, Czechia
Recruiting
- Ascentage Investigative Site
Clermont-Ferrand, France
Recruiting - Ascentage Investigative Site
Le Mans, France
Recruiting - Ascentage Investigative Site
Lyon, France
Recruiting - Ascentage Investigative Site
Nantes, France
Recruiting - Ascentage Investigative Site
Nantes, France
Recruiting - Ascentage Investigative Site
Nîmes, France
Recruiting - Ascentage Investigative Site
Orléans, France
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Dec 2023
- Primary completion
- 31 Dec 2026
- Completion
- 31 Oct 2027
- Last update posted
- 18 Jun 2026
- Registered enrollment
- 400
- Registry id
- NCT06104566
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.